Abstract | PURPOSE: RESULTS: Initial visual acuity was 1.3/10 at 9 months, which was minimal follow-up. Twenty-three patients had total resumption of retinal pigment epithelium detachment on optical coherence tomography imaging after 1 month. One patient had ocular hypertension and needed trabeculectomy, one had a pigment epithelium break but with good functional results. Seven patients needed six intravitreous injections of ranibizumab with partial or total resumption in six cases. DISCUSSION: CONCLUSION: Treatment of retinal pigment epithelium detachment is difficult. Associating intravitreous injection of ranibizumab, dynamic phototherapy, and subtenon triamcinolone provides good results.
|
Authors | N Hajouli, A Hiesch, J-C Quintyn |
Journal | Journal francais d'ophtalmologie
(J Fr Ophtalmol)
Vol. 33
Issue 7
Pg. 487-92
(Sep 2010)
ISSN: 1773-0597 [Electronic] France |
Vernacular Title | Traitement des décollements de l'épithélium pigmentaire par photothérapie dynamique, IVT de ranibizumab, sous-ténonienne de triamcinolone. |
PMID | 20452090
(Publication Type: Clinical Trial, English Abstract, Journal Article)
|
Copyright | Copyright © 2010 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Triamcinolone Acetonide
- Ranibizumab
|
Topics |
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal
(administration & dosage)
- Antibodies, Monoclonal, Humanized
- Choroidal Neovascularization
(complications)
- Combined Modality Therapy
- Female
- Humans
- Intravitreal Injections
- Macular Degeneration
(complications)
- Male
- Photochemotherapy
- Prospective Studies
- Ranibizumab
- Retinal Detachment
(complications, drug therapy)
- Triamcinolone Acetonide
(therapeutic use)
|